Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new NIH funding entry for 2018 was added to the study's identifiers. This updates the record to reflect U.S. NIH support for KEYNOTE-799.
    Difference
    0.0%
    Check dated 2026-08-25T19:49:58.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a minor update to the page's build. This does not modify the study details or other user-visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:30:10.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new version of the page’s documentation. This reflects an internal update to the page’s revision history rather than a substantive alteration to study details.
    Difference
    0.0%
    Check dated 2026-07-28T12:27:13.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3, signaling a newer page revision. This update appears to be a maintenance/format change rather than a modification to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-30T01:16:12.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited and adds new sections to help readers read the study record, understand common questions, and learn how to join the study. It also includes a minor formatting change to the Intervention/Treatment label and updates the revision note to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T18:20:23.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.5) in the footer, replacing the previous v3.5.4. This indicates a minor internal update to the page rendering or maintenance.
    Difference
    0.0%
    Check dated 2026-06-08T14:54:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.